Jump Financial »

Aardvark Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $454k 35k 13.13

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Polygon Management
Geode Capital Management
Silverarc Capital Management
Two Sigma Investments
State Street Corporation
UBS Group
AQR Capital Management
Millennium Management
Northern Trust

View all funds holding Aardvark Therapeutics